Seema K. Singh

Seema K. Singh

Hospital Medicine

111 South 11th Street
Philadelphia, PA 19107

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 232 publications

Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes.

Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes.

Journal: Alimentary pharmacology & therapeutics

Published: February 02, 2026

Genomic landscape and precision therapy in prostate cancer: current status and future directions.

Genomic landscape and precision therapy in prostate cancer: current status and future directions.

Journal: NPJ precision oncology

Published: November 20, 2025

Clinical Trial: Semaglutide Versus Placebo in NIT-Assessed MASH-A Multicenter Randomised Placebo-Controlled Trial (SAMARA).

Clinical Trial: Semaglutide Versus Placebo in NIT-Assessed MASH-A Multicenter Randomised Placebo-Controlled Trial (SAMARA).

Journal: Alimentary pharmacology & therapeutics

Published: November 03, 2025

Smoking Behavior Is Associated With an Altered Immune Landscape in Prostate Cancer: Implications for Patient Outcomes.

Smoking Behavior Is Associated With an Altered Immune Landscape in Prostate Cancer: Implications for Patient Outcomes.

Journal: The Prostate

Published: August 28, 2025

The MetALD-ALD Prediction Index: A Phosphatidylethanol-Driven Biomarker Panel for Identifying Individuals With Steatotic Liver Disease and Excessive Alcohol Use.

The MetALD-ALD Prediction Index: A Phosphatidylethanol-Driven Biomarker Panel for Identifying Individuals With Steatotic Liver Disease and Excessive Alcohol Use.

Journal: Gastroenterology

Published: July 17, 2025

MYB/AKT3 axis is a key driver of ovarian cancer growth, aggressiveness, and chemoresistance.

MYB/AKT3 axis is a key driver of ovarian cancer growth, aggressiveness, and chemoresistance.

Journal: Journal of ovarian research

Published: June 26, 2025

MYB and HIF1α crosstalk drives hypoxia-induced transcriptional reprogramming and adaptive signaling alterations in pancreatic cancer.

MYB and HIF1α crosstalk drives hypoxia-induced transcriptional reprogramming and adaptive signaling alterations in pancreatic cancer.

Journal: Cancer letters

Published: May 30, 2025

Subtype- and race-specific variations in the immune landscape of breast cancer: therapeutic implications.

Subtype- and race-specific variations in the immune landscape of breast cancer: therapeutic implications.

Journal: NPJ breast cancer

Published: May 28, 2025

Clinical utility of phosphatidylethanol to detect underreported alcohol use and enhance steatotic liver disease subclassification.

Clinical utility of phosphatidylethanol to detect underreported alcohol use and enhance steatotic liver disease subclassification.

Journal: Journal of hepatology

Published: January 21, 2025

Head-to-Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study.

Head-to-Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study.

Journal: Alimentary pharmacology & therapeutics

Published: December 10, 2024

HIF-2α drives hepatic Kupffer cell death and proinflammatory recruited macrophage activation in nonalcoholic steatohepatitis.

HIF-2α drives hepatic Kupffer cell death and proinflammatory recruited macrophage activation in nonalcoholic steatohepatitis.

Journal: Science translational medicine

Published: September 11, 2024

Obesity and Early-Onset Breast Cancer and Specific Molecular Subtype Diagnosis in Black and White Women: NIMHD Social Epigenomics Program.

Obesity and Early-Onset Breast Cancer and Specific Molecular Subtype Diagnosis in Black and White Women: NIMHD Social Epigenomics Program.

Journal: JAMA network open

Published: July 29, 2024

Showing 1-12 of 232

Last Updated: 09/26/2026